Sequence-dependent DNA structure: the role of the sugar-phosphate backbone.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMID 9665845)

Published in J Mol Biol on July 17, 1998

Authors

M J Packer1, C A Hunter

Author Affiliations

1: Department of Chemistry, University of Sheffield, Sheffield, S3 7HF, England.

Articles by these authors

Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens. J Immunol (2001) 2.70

Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling. J Immunol (1999) 2.53

Sequence-dependent DNA structure: tetranucleotide conformational maps. J Mol Biol (2000) 2.13

Advances in understanding the anti-inflammatory properties of IL-27. Immunol Lett (2008) 2.04

IL-10 mediates susceptibility to Leishmania donovani infection. Eur J Immunol (2001) 1.99

Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest (1998) 1.93

Sequence-dependent DNA structure: dinucleotide conformational maps. J Mol Biol (2000) 1.86

Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. J Immunol (1992) 1.83

Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology (1995) 1.76

Mitogen- and antigen-specific proliferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediates. Infect Immun (1994) 1.66

Host-pathogen interactions: subversion and utilization of the NF-kappa B pathway during infection. Infect Immun (2002) 1.65

An Epidemic of Diarrhea in a New-Born Nursery Caused by Pseudomonas aeruginosa. Am J Public Health Nations Health (1947) 1.51

Inhibition of interferon gamma induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor. Proc Natl Acad Sci U S A (1998) 1.50

gp130 at the nexus of inflammation, autoimmunity, and cancer. J Leukoc Biol (2010) 1.48

IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-gamma when combined with IL-18. Eur J Immunol (1999) 1.45

Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Infect Immun (1997) 1.44

IL-1 alpha and TNF-alpha are required for IL-12-induced development of Th1 cells producing high levels of IFN-gamma in BALB/c but not C57BL/6 mice. J Immunol (1998) 1.38

Structure and conformation of helical nucleic acids: analysis program (SCHNAaP). J Mol Biol (1997) 1.36

The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis. Infect Immun (2000) 1.31

Suppression of NF-kappaB activation by infection with Toxoplasma gondii. J Infect Dis (2002) 1.24

The NF-kappa B family member RelB is required for innate and adaptive immunity to Toxoplasma gondii. J Immunol (1999) 1.22

Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii. Infect Immun (2000) 1.21

Immune suppression by recombinant interleukin (rIL)-12 involves interferon gamma induction of nitric oxide synthase 2 (iNOS) activity: inhibitors of NO generation reveal the extent of rIL-12 vaccine adjuvant effect. J Exp Med (1998) 1.20

IL-18 and CD28 use distinct molecular mechanisms to enhance NK cell production of IL-12-induced IFN-gamma. J Immunol (1999) 1.20

A DNA damage and stress inducible G protein-coupled receptor blocks cells in G2/M. Proc Natl Acad Sci U S A (1998) 1.18

The CD28/B7 interaction is not required for resistance to Toxoplasma gondii in the brain but contributes to the development of immunopathology. J Immunol (1999) 1.14

Roles of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and toxoplasma antigen during acute toxoplasmosis. Infect Immun (1995) 1.13

Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii. J Immunol (2000) 1.13

Advances in the use of genetically engineered parasites to study immunity to Toxoplasma gondii. Parasite Immunol (2008) 1.12

Anti-TGF-beta treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production. J Immunol (1999) 1.08

Identification of a role for NF-kappa B2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii. J Immunol (2000) 1.07

Structure and conformation of helical nucleic acids: rebuilding program (SCHNArP). J Mol Biol (1997) 1.06

Immunoregulation during toxoplasmosis. Chem Immunol (1998) 1.06

Role of CD28 in the generation of effector and memory responses required for resistance to Toxoplasma gondii. J Immunol (1999) 1.01

Enhancement of intracellular replication of Toxoplasma gondii by IL-6. Interactions with IFN-gamma and TNF-alpha. J Immunol (1994) 1.01

Preferential activation and expansion of human peripheral blood gamma delta T cells in response to Toxoplasma gondii in vitro and their cytokine production and cytotoxic activity against T. gondii-infected cells. J Clin Invest (1995) 0.99

Temporal differences in the expression of mRNA for IL-10 and IFN-gamma in the brains and spleens of C57BL/10 mice infected with Toxoplasma gondii. Parasite Immunol (1994) 0.99

Negative regulation of Th17 responses. Semin Immunol (2008) 0.99

Targeted disruption of the bradyzoite-specific gene BAG1 does not prevent tissue cyst formation in Toxoplasma gondii. Mol Biochem Parasitol (1998) 0.97

Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice. Infect Immun (2000) 0.94

A role for CD44 in the production of IFN-gamma and immunopathology during infection with Toxoplasma gondii. J Immunol (2001) 0.92

Intestinal pathology during acute toxoplasmosis is IL-4 dependent and unrelated to parasite burden. Parasite Immunol (2004) 0.91

Quantitative measurements of edge-to-face aromatic interactions by using chemical double-mutant cycles. Chemistry (2001) 0.91

Quantitative determination of intermolecular interactions with fluorinated aromatic rings. Chemistry (2001) 0.89

IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii. Parasite Immunol (2004) 0.88

A supramolecular system for quantifying aromatic stacking interactions. Chemistry (2001) 0.87

Dichloroacetate improves cardiac efficiency after ischemia independent of changes in mitochondrial proton leak. Am J Physiol Heart Circ Physiol (2001) 0.86

Chemotherapy of Trypanosoma brucei infection of the central nervous system: the use of a rapid chemotherapeutic regimen and the development of post-treatment encephalopathies. Trans R Soc Trop Med Hyg (1993) 0.83

Interleukin-10 does not contribute to the pathogenesis of a virulent strain of Toxoplasma gondii. Parasite Immunol (2001) 0.83

Patients infected with Leishmania donovani chagasi can have antibodies that recognize heat shock and acidic ribosomal proteins of Trypanosoma cruzi. Mol Biochem Parasitol (1991) 0.82

The role of the polyamine inhibitor eflornithine in the neuropathogenesis of experimental murine African trypanosomiasis. Neuropathol Appl Neurobiol (1997) 0.81

Detection of volatile organic compounds using porphyrin derivatives. J Phys Chem B (2010) 0.79

Alkylamine sensing using langmuir-blodgett films of n-alkyl-N-phenylamide-substituted zinc porphyrins. J Phys Chem B (2008) 0.79

Presence of delta-sleep-inducing peptide-like material in human milk. J Clin Endocrinol Metab (1984) 0.79

Altered endochondral ossification in collagen X mouse models leads to impaired immune responses. Dev Dyn (2008) 0.78

Sequence-structure relationships in DNA oligomers: a computational approach. J Am Chem Soc (2001) 0.78

Similarity in variable antigen type composition of Trypanosoma brucei rhodesiense populations in different sites within the mouse host. Trans R Soc Trop Med Hyg (1986) 0.77

Immunity to Toxoplasma gondii--into the 21st century. Parasite Immunol (2015) 0.77

Self-assembly of oligomeric porphyrin rings. Org Lett (2000) 0.77

Treatment with interleukin 12 in combination with atovaquone or clindamycin significantly increases survival of mice with acute toxoplasmosis. Antimicrob Agents Chemother (1997) 0.76

Passive stretch relationships in human uterine muscle. Am J Obstet Gynecol (1966) 0.76

Toxoplasma gondii induces changes in intracellular calcium in macrophages. Parasitology (2007) 0.75

Immune deficiencies and parasitic diseases. Parasite Immunol (2006) 0.75

Effect of pudendal, spinal, and peridural block anesthesia on the second stage of labor. Am J Obstet Gynecol (1972) 0.75

Intrauterine fetal transfusion for severe Rh disease. Northwest Med (1968) 0.75

Comparison of spontaneous, oxytocin-stimulated, and hypertonic saline-induced labor by different methods of record analysis. Am J Obstet Gynecol (1970) 0.75

Aluminum phthalocyanine-streptavidin: new, sensitive fluorescent tracer for immunoassay. Clin Chem (1991) 0.75

The role of natural killer cells in innate resistance to infection. J Immunol (1997) 0.75

Obstetrical management of the Rh negative patient. S D J Med (1965) 0.75

Current status of the first postdoctoral year. Present concepts from American surgical boards: obstetrics and gynecology. Bull Am Coll Surg (1975) 0.75

The goal of learning--to be enlightened. Presidential address. Am J Obstet Gynecol (1976) 0.75

Dysfunction of the forces of labor. Clin Anesth (1965) 0.75

Biodegradable microspheres: polyacryl starch microparticles as a delivery system for the antileishmanial drug, sodium stibogluconate. J Pharm Pharmacol (1987) 0.75

Continuum of medical education in obstetrics and gynecology. J Med Educ (1980) 0.75

Effects of intra-amniotic injection of hypertonic saline on uterine activity, blood and amniotic fluid volumes, and electrolyte concentrations. Am J Obstet Gynecol (1968) 0.75

Methodology and evaluation of undergraduate curriculum in obstetrics and gynecology. Am J Obstet Gynecol (1969) 0.75